Connect with us

Life Sciences

ADDMAN Expands Polymer Additive and Quick-Turn Capabilities via Dinsmore Acquisition

ADDMAN Engineering (“ADDMAN”) announced that it had acquired Dinsmore & Associates (“Dinsmore”, or “Company”), an Irvine, California-based…

Published

on

This article was originally published by AITHORITY
ADDMAN Expands Polymer Additive and Quick-Turn Capabilities via Dinsmore Acquisition

ADDMAN Engineering (“ADDMAN”) announced that it had acquired Dinsmore & Associates (“Dinsmore”, or “Company”), an Irvine, California-based provider of polymer 3D printing services, to its manufacturing solutions network. The addition of Dinsmore broadens ADDMAN’s polymer production capability and is highly complementary to its existing additive and traditional manufacturing services.

Founded in 2002, Dinsmore is one of the pioneers of additive manufacturing technology in the United States known for its engineering-focused, value-added go-to-market approach, rapid manufacturing competences and quality. Dinsmore supports product design and development, prototyping and low-volume production for customers with a focus in medical applications. The company operates over 35 additive machines using leading technologies such as MJF, PolyJet, DLS, DLP, SLA, FFF and FDM, and can turn around production as quickly as under 5 days.

AI NewsAn Investment Into Artificial Intelligence as Daktela Buys Coworkers.ai

Joe Calmese, CEO of ADDMAN, states “This announcement marks the expansion of ADDMAN’s ability to support medical industry partners. We are planning for significant investment and growth in this arena going forward, and Dinsmore will serve as a core part of this strategy…By joining forces with Dinsmore, we now have one of the largest rosters of AMUG-awarded DINOs under one roof.” The Additive Manufacturing User Group (AMUG) awards Distinguished Innovator Operators Awards (DINO) honors top leaders in the additive field. ADDMAN’s five DINOs include: Dr. Youping GaoBob MarkleyJay DinsmoreBill Braune, and Jason Lopes.

Jay Dinsmore, Founder and CEO of Dinsmore, adds “ADDMAN operates with a level of integrity and understanding of additive that matches the high value proposition that is synonymous with the Dinsmore brand. I’m happy to be a driving force in expanding their polymer business…Now that we are a part of the ADDMAN network, we can deliver a suite of new services, such as injection molding, CNC machining, metal additive manufacturing, and ISO 13485 cleanroom molded parts. This move extends our capacity to support customers through their complete product lifecycle.”

Latest AI/NLP Technology Insights: ProcessUnity Acquires AI/NLP Technology from ISMS Solutions

Sunny Li, Partner at American Industrial Partners, commented “AIP views additive manufacturing as one of the most impactful and disruptive technologies within the industrial economy. The acquisition of Dinsmore puts us one step closer to our vision of creating an additive-enabled, vertically integrated, and engineering-focused industrial technology business.”

Latest Aithority Insights : Got It AI Announces AutoFlows, a Breakthrough Autonomous Conversational AI

 [To share your insights with us, please write to sghosh@martechseries.com] 

The post ADDMAN Expands Polymer Additive and Quick-Turn Capabilities via Dinsmore Acquisition appeared first on AiThority.



artificial intelligence

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending